XinKePing 欣可平 (Avatrombopag) 20mg*10 Tablets | Nanjing Hencer China | GLT

Generic Information: XinKePing (Avatrombopag) — Nanjing Hencer, Jemcare Group

XinKePing (欣可平) is the avatrombopag maleate tablet of Nanjing Hencer Pharmaceutical Co., Ltd. — the company behind the hencer.com domain, a wholly owned member of the Jemcare pharmaceutical group (济民可信) whose name appears on the carton beside the brand. Hencer built its reputation in iron preparations and nephrology before expanding into complex generics, and its avatrombopag file was developed in-house at the group's research institute, with the API synthesized in-house too: raw material and finished tablet cleared their Chinese reviews back to back, a vertically integrated route only a handful of domestic filers achieved. Approval number: 国药准字H20244403; pack: ten 20 mg film-coated tablets.

What Is XinKePing Used For?

The registered population is adults with chronic liver disease related thrombocytopenia who are scheduled for elective diagnostic procedures or surgery — the short pre-procedure course that replaces platelet transfusion planning. Like several of its domestic peers, the group's filings document the wider program toward the ITP indication that the originator established; prescribers currently manage XinKePing primarily in the hepatology and transplant-preparation setting where Chinese guidelines position the class. Chronic liver disease patients are reminded on the label itself that the drug serves the procedure window, not permanent count normalization.

How Does XinKePing Work?

Avatrombopag maleate dissolves to deliver avatrombopag, which activates the thrombopoietin receptor (c-Mpl) on megakaryocyte progenitors from the transmembrane domain — a second-generation binding mode that leaves the natural TPO site untouched, so endogenous hormone and drug push the same pathway together. Megakaryocytes mature and shed platelets within days. Because the molecule is non-peptide and metal-free, meals, dairy and common co-medications do not impair absorption — a genuine operational advantage for cirrhotic patients on polypharmacy.

Indications of XinKePing (China Label)

The insert states: thrombocytopenia in adult patients with chronic liver disease scheduled to undergo elective diagnostic procedures or surgery. Hencer's dual filing capability (API plus tablet) supports supply continuity for this indication across Chinese hospital networks, and the Jemcare group's national distribution reaches secondary hospitals that imported-only supply historically missed. Any broader use — ITP maintenance, antiviral-related counts — is a specialist's off-label territory for now.

Dosage and Administration

Once daily with food, tablets swallowed whole. In the CLD course: begin ten to thirteen days before the procedure; below 40×10⁹/L platelets, take three tablets (60 mg) daily for five days; from 40 to under 50×10⁹/L, take two tablets (40 mg) daily for five days; undergo the procedure five to eight days after the last tablet. Blood counts are re-checked on the day of the procedure to confirm the target was reached. A missed dose is taken as soon as remembered with food — never doubled.

Side Effects of XinKePing

The observed pattern matches the class: fever, headache, stomach pain, nausea, tiredness and peripheral swelling are the frequent entries in liver-disease trials. The serious flagged risk — thromboembolism as platelets climb — is managed with scheduled counts and dose reduction at overshoot; warning signs such as leg pain with swelling, sudden breathlessness or chest pain need emergency care. Hypersensitivity to any ingredient is the absolute bar.

Storage Instructions

Store below 25°C in the original package, dry, protected from light; the carton itself prints the temperature line. No refrigeration. Keep away from children and dispose of surplus tablets via pharmacy channels.

Why Choose XinKePing from GLT?

XinKePing appeals to buyers who weigh manufacturing pedigree: Jemcare ranks among China's top-ten pharma groups by revenue, Hencer's plants have cleared multiple foreign GMP audits for its export lines, and the API-plus-tablet integration means fewer single-point supply risks. GLT supplies sealed mainland boxes with the H20244403 number legible, together with batch photographs pre-dispatch, comparative quotations against the originator and other generics, and direct human contact at WhatsApp +86 15234153837 or [email protected] from enquiry to delivery.

How to Order XinKePing (Avatrombopag)

Contact WhatsApp +86 15234153837 or email [email protected] with quantity and destination country. GLT returns a formal quotation with courier and payment options, generally within one working day, and ships sealed cartons with full export documentation once confirmed. Institutional buyers can arrange CoA review and scheduled resupply.

FAQ

Who makes XinKePing? Nanjing Hencer Pharmaceutical Co., Ltd., a wholly owned subsidiary of the Jemcare (济民可信) group — approval H20244403.

What does API integration mean for me as a buyer? The same company makes the active ingredient and the tablet, so supply is less exposed to raw-material disruption and quality control runs across the whole chain.

Why is only the CLD indication listed right now? Hencer's registration currently centers the liver-disease procedure indication; the ITP extension follows the originator's regulatory path and belongs to the maker's filing schedule.

Is欣可平 the same strength as the imported original? Yes — 20 mg film-coated tablets, ten per box, manufactured under China's consistency-evaluation standards.

How quickly does it work before surgery? Counts begin rising within three to five days of starting, which is why the course starts ten to thirteen days ahead and the procedure follows five to eight days after the last tablet.